Citation: Nb. Tsavaris et Ga. Pangalis, NEUTROPHIL 5-NUCLEOTIDASE REACTION IN CHRONIC MYELOGENOUS LEUKEMIA, MYELOFIBROSIS WITH MYELOID METAPLASIA, AND POLYCYTHEMIA-VERA, Annals of hematology, 76(1), 1998, pp. 1-5
Citation: Nb. Tsavaris et C. Kosmas, RISK OF SEVERE ACUTE HYPERSENSITIVITY REACTIONS AFTER RAPID PACLITAXEL INFUSION OF LESS-THAN 1-H DURATION, Cancer chemotherapy and pharmacology, 42(6), 1998, pp. 509-511
Authors:
BAXEVANIS CN
TSAVARIS NB
PAPADHIMITRIOU SI
ZARKADIS IK
PAPADOPOULOS NG
BASTOUNIS EA
PAPAMICHAIL M
Citation: Cn. Baxevanis et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IMPROVES IMMUNOLOGICAL PARAMETERS IN PATIENTS WITH REFRACTORY SOLID TUMORS RECEIVING 2ND-LINE CHEMOTHERAPY - CORRELATION WITH CLINICAL-RESPONSES, European journal of cancer, 33(8), 1997, pp. 1202-1208
Authors:
TSAVARIS NB
TENTAS K
KOSMIDIS P
MYLONAKIS N
SAKELAROPOULOS N
KOSMAS C
LISAIOS B
SOUMILAS A
MANDREKOIS D
TSETIS A
KLONARIS C
Citation: Nb. Tsavaris et al., 5-FLUOROURACIL, EPIRUBICIN, AND MITOMYCIN-C VERSUS 5-FLUOROURACIL, EPIRUBICIN, MITOMYCIN-C, AND LEUCOVORIN IN ADVANCED GASTRIC-CARCINOMA - A RANDOMIZED TRIAL, American journal of clinical oncology, 19(5), 1996, pp. 517-521
Authors:
TSAVARIS NB
TSAROUCHANOUTSOU E
KARVOUNIS N
BACOYANNIS C
PAGOU M
KOSMIDIS P
Citation: Nb. Tsavaris et al., COMPARISON OF DIFFERENT SCHEDULES OF ONDANSETRON (GR 38032F) ADMINISTRATION DURING CISPLATIN-BASED CHEMOTHERAPY - A RANDOMIZED TRIAL, Chemotherapy, 41(1), 1995, pp. 70-76
Citation: Nb. Tsavaris et P. Kosmidis, ANALYSIS OF TUMOR-MARKERS CEA, CA-125, CA-15.3 AND PROLACTIN LEVELS IN PATIENTS WHO WERE FOLLOWED UP FOR BREAST-CANCER, Diagnostic oncology, 3(4), 1993, pp. 221-222